Thymoma is associated with an increased risk of second malignancy - PubMed (original) (raw)
Comparative Study
Thymoma is associated with an increased risk of second malignancy
C C Pan et al. Cancer. 2001.
Abstract
Background: An association between thymoma and second malignancy has been suggested but has not been validated. Whether the relation is due to treatment or to other thymoma-associated conditions is unclear.
Methods: The authors studied 192 consecutive patients with thymoma and compared the incidence of second malignancies with those of 206 patients who underwent thymectomy for nonthymomatous conditions and 1426 patients with nasopharyngeal carcinoma (NPC). Detailed clinicopathologic features of thymoma patients with second malignancies were described.
Results: Additional malignancies were detected in 15 of 192 patients (8%) during their clinical courses. The risk for those patients was significantly greater compared with the risk for patients with nonthymomatous conditions (adjusted odds ratio [OR], 3.81; 95% confidential intervals [95%CI], 1.05-13.81; P = 0.042) and patients with NPC (adjusted OR, 4.89; 95%CI, 2.26-10.53; P < 0.0001) after adjustment for age, gender, length of follow-up, myasthenia gravis, and radiation therapy. The occurrence of second malignancies did not correlate with histologic type or stage of thymoma, radiation therapy, or myasthenia gravis.
Conclusions: Thymoma is associated with an increased risk of second malignancy. The association cannot be attributed to the effect of thymectomy or radiation therapy. Patients with thymoma, even if it is benign, should be followed regularly to facilitate the early detection of other malignancies.
Copyright 2001 American Cancer Society.
Similar articles
- Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis.
Xue L, Wang L, Dong J, Yuan Y, Fan H, Zhang Y, Wang Q, Ding J. Xue L, et al. Eur J Cardiothorac Surg. 2017 Oct 1;52(4):692-697. doi: 10.1093/ejcts/ezx163. Eur J Cardiothorac Surg. 2017. PMID: 29156018 - Thymectomy and malignancy.
Masaoka A, Yamakawa Y, Niwa H, Fukai I, Saito Y, Tokudome S, Nakahara K, Fujii Y. Masaoka A, et al. Eur J Cardiothorac Surg. 1994;8(5):251-3. doi: 10.1016/1010-7940(94)90155-4. Eur J Cardiothorac Surg. 1994. PMID: 8043287 Review. - Second malignancy versus recurrence after complete resection of thymoma.
Hamaji M, Sozu T, Machida R, Omasa M, Menju T, Aoyama A, Sato T, Chen-Yoshikawa TF, Sonobe M, Date H. Hamaji M, et al. Asian Cardiovasc Thorac Ann. 2018 May;26(4):290-295. doi: 10.1177/0218492318765872. Epub 2018 Mar 11. Asian Cardiovasc Thorac Ann. 2018. PMID: 29528688 - Neurologic outcomes of thymectomy in myasthenia gravis: comparative analysis of the effect of thymoma.
Kim HK, Park MS, Choi YS, Kim K, Shim YM, Han J, Kim BJ, Kim J. Kim HK, et al. J Thorac Cardiovasc Surg. 2007 Sep;134(3):601-7. doi: 10.1016/j.jtcvs.2007.05.015. J Thorac Cardiovasc Surg. 2007. PMID: 17723805 - The long-term clinical outcome of myasthenia gravis in patients with thymoma.
Bril V, Kojic J, Dhanani A. Bril V, et al. Neurology. 1998 Oct;51(4):1198-200. doi: 10.1212/wnl.51.4.1198. Neurology. 1998. PMID: 9781560 Review.
Cited by
- Radiation dose for thymic tumours.
Lalani N, Brade AM. Lalani N, et al. Mediastinum. 2020 Dec 30;4:35. doi: 10.21037/med-20-4. eCollection 2020. Mediastinum. 2020. PMID: 35118303 Free PMC article. Review. - Thymoma and multiple malignancies: a case of five synchronous neoplasms and literature review.
Welsh JS, Thurman SA, Howard SP. Welsh JS, et al. Clin Med Res. 2003 Jul;1(3):227-32. doi: 10.3121/cmr.1.3.227. Clin Med Res. 2003. PMID: 15931312 Free PMC article. Review. - Rationale and early outcomes for the management of thymoma with proton therapy.
Zhu HJ, Hoppe BS, Flampouri S, Louis D, Pirris J, Nichols RC, Henderson RH, Mercado CE. Zhu HJ, et al. Transl Lung Cancer Res. 2018 Apr;7(2):106-113. doi: 10.21037/tlcr.2018.04.06. Transl Lung Cancer Res. 2018. PMID: 29876309 Free PMC article. - CHEST PAIN DUE TO A GIANT THYMOMA IN AN ADOLESCENT BOY.
Pacurar D, Tincu I, Muntean A, Lesanu G, Oraseanu D, Cordos I. Pacurar D, et al. Acta Endocrinol (Buchar). 2016 Jan-Mar;12(1):96-101. doi: 10.4183/aeb.2016.96. Acta Endocrinol (Buchar). 2016. PMID: 31258809 Free PMC article. - Deciphering tissue-based proteome signatures revealed novel subtyping and prognostic markers for thymic epithelial tumors.
Ku X, Sun Q, Zhu L, Gu Z, Han Y, Xu N, Meng C, Yang X, Yan W, Fang W. Ku X, et al. Mol Oncol. 2020 Apr;14(4):721-741. doi: 10.1002/1878-0261.12642. Epub 2020 Feb 6. Mol Oncol. 2020. PMID: 31967407 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical